ArticleCancer chemotherapy and pharmacology2026
Characterizing P-glycoprotein and Breast Cancer Resistance Protein interactions of asciminib among other tyrosine kinase inhibitors used in chronic myeloid leukemia.
N E Verhagen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.